Victoria Hagelstein
Luebeck, SH 23562, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Retrospective Analysis of the Prognostic Factors and Adverse Events in the Treatment of Mucosal Melanoma in a Single Centre.
Journal: Journal of clinical medicine
Published: June 19, 2024
Variants in the TERT Gene Increase the Occurrence of Solar Lentigines by Modifying Telomerase Expression Exclusively in the Skin.
Journal: The Journal of investigative dermatology
Published: July 26, 2023
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center.
Journal: International journal of molecular sciences
Published: July 29, 2022
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 03, 2022
Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failure.
Journal: Melanoma research
Published: July 20, 2021
The impact of the Covid-19 pandemic on quality of life in skin cancer patients.
Journal: PloS one
Published: February 17, 2021
Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 10, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026